Perivascular delivery of blebbistatin reduces neointimal hyperplasia after carotid injury in the mouse

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 1, 2011, Pages 116-126

  Huang, Jianhua ^a   Zhang, Jianxin ^b   Pathak, Alokkumar ^a   Li, Juxiang ^a   Stouffer, George A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BLEBBISTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY INJURY; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DRUG DELIVERY SYSTEM; DRUG EFFECT; FIBROMUSCULAR DYSPLASIA; MOUSE; NEOINTIMAL HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS; REVASCULARIZATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HYPERPLASIA; MALE; MICE; MICE, INBRED C57BL; NEOINTIMA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA;

EID: 78650774610     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.174615     Document Type: Article

References (27)

1. Aikawa M, Sakomura Y, Ueda M, Kimura K, Manabe I, Ishiwata S, Komiyama N, Yamaguchi H, Yazaki Y, and Nagai R (1997) Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 96:82-90.
2. Allingham JS, Smith R, and Rayment I (2005) The structural basis of blebbistatin inhibition and specificity for myosin II. Nat Struct Mol Biol 12:378-379.
3. Choi ET, Khan MF, Leidenfrost JE, Collins ET, Boc KP, Villa BR, Novack DV, Parks WC, and Abendschein DR (2004) Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice. Circulation 109:1564-1569.
4. Christen T, Verin V, Bochaton-Piallat M, Popowski Y, Ramaekers F, Debruyne P, Camenzind E, van Eys G, and Gabbiani G (2001) Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 103:882-888.
5. De Leon H, Scott NA, Martin F, Simonet L, Bernstein KE, and Wilcox JN (1997) Expression of nonmuscle myosin heavy chain-B isoform in the vessel wall of porcine coronary arteries after balloon angioplasty. Circ Res 80:514-519.
6. Doran AC, Meller N, and McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812-819.
7. Eddinger TJ, Meer DP, Miner AS, Meehl J, Rovner AS, and Ratz PH (2007) Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin. J Pharmacol Exp Ther 320:865-870.
8. Gallagher PJ, Jin Y, Killough G, Blue EK, and Lindner V (2000) Alterations in expression of myosin and myosin light chain kinases in response to vascular injury. Am J Physiol Cell Physiol 279:C1078-C1087.
9. Herdeg C, Oberhoff M, Baumbach A, Schroeder S, Leitritz M, Blattner A, Siegel-Axel DI, Meisner C, and Karsch KR (2003) Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery. Cardiovasc Res 57:544-553.
10. Huang J and Kontos CD (2002) PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 277:10760-10766.
11. Katayama T, Yoshiyama S, Tanaka H, Wang HH, Nakamura A, and Kohama K (2006) Blebbistatin inhibits sphingosylphosphorylcholine-induced contraction of collagen-gel fiber populated by vascular smooth-muscle cells. J Pharmacol Sci 102:339-342.
12. Kolega J (2004) Phototoxicity and photoinactivation of blebbistatin in UV and visible light. Biochem Biophys Res Commun 320:1020-1025.
13. Kumar A and Lindner V (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17:2238-2244.
14. Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H, Yazaki Y, Ohkubo A, and Takaku F (1991) cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 266:3768-3773.
15. Li G, Chen SJ, Oparil S, Chen YF, and Thompson JA (2000) Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101:1362-1365.
16. Lindner V, Fingerle J, and Reidy MA (1993) Mouse model of arterial injury. Circ Res 73:792-796.
17. Lo CM, Buxton DB, Chua GC, Dembo M, Adelstein RS, and Wang YL (2004) Nonmuscle myosin IIb is involved in the guidance of fibroblast migration. Mol Biol Cell 15:982-989.
18. Owens GK (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487-517.
19. Pires NM, van der Hoeven BL, de Vries MR, Havekes LM, van Vlijmen BJ, Hennink WE, Quax PH, and Jukema JW (2005) Local perivascular delivery of antirestenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff. Biomaterials 26:5386-5394.
20. Sajid M, Hu Z, Lele M, and Stouffer GA (2000) Protein complexes involving αvβ3 integrins, nonmuscle myosin heavy chain-A and focal adhesion kinase form in thrombospondin-treated smooth muscle cells. J Investig Med 48:190-197.
21. Sartore S, Chiavegato A, Franch R, Faggin E, and Pauletto P (1997) Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease. Arterioscler Thromb Vasc Biol 17:1210-1215.
22. Sartore S, Scatena M, Chiavegato A, Faggin E, Giuriato L, and Pauletto P (1994) Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J Vasc Res 31:61-81.
23. Signore PE, Machan LS, Jackson JK, Burt H, Bromley P, Wilson JE, and McManus BM (2001) Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J Vasc Interv Radiol 12:79-88.
24. Simons M and Rosenberg RD (1992) Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 70:835-843.
25. Stouffer GA and Owens GK (1994) TGF-β promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest 93:2048-2055.
26. Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, and Mitchison TJ (2003) Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299:1743-1747.
27. Wang HH, Tanaka H, Qin X, Zhao T, Ye LH, Okagaki T, Katayama T, Nakamura A, Ishikawa R, Thatcher SE, et al. (2008) Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction. Am J Physiol Heart Circ Physiol 294:H2060-H2068.